Trial site
Praglandia s.r.o.
- 34running trials
- 19closed trials
The trials here
What the 53 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)20 trials
- Obesity9 trials
- Psoriasis8 trials
- Depression4 trials
- Psoriatic arthritis4 trials
- High blood pressure3 trials
- Migraine3 trials
- Obstructive sleep apnoea3 trials
- Type 2 diabetes3 trials
- Alzheimer disease2 trials
- Chronic kidney disease2 trials
- Parkinson disease2 trials
- and 5 more
- Phase
- Phase 332 trials
- Phase 220 trials
- Phase 2/31 trial
- Status
- Completed19 trials
- Active, not recruiting15 trials
- Not yet recruiting10 trials
- Recruiting9 trials
- Lead sponsor
- Eli Lilly and Company8 trials
- Sanofi5 trials
- Takeda5 trials
- AbbVie2 trials
- Alumis Inc2 trials
- and 24 more
Running trials
Not yet recruiting
Not yet recruiting
Not yet recruiting
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults with Moderate-to-Severe Atopic Dermatitis
Recruiting
Recruiting
Recruiting
Recruiting
A Trial Investigating Lu AF28996 in Adults With Parkinson's Disease Who Have Motor Fluctuations
Recruiting
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
Enrolling by invitation
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
Recruiting
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Not yet recruiting
Recruiting
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Recruiting
Active, not recruiting
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
Active, not recruiting
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Active, not recruiting
Active, not recruiting
Terminated
Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atopic dermatitis (eczema)7 recruiting
- Alzheimer disease2 recruiting
- Depression2 recruiting
- Obesity2 recruiting
- Psoriasis2 recruiting
- Psoriatic arthritis2 recruiting
- Schizophrenia2 recruiting
- Type 2 diabetes2 recruiting
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- Parkinson disease1 recruiting
- Stroke1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
Completed
Completed
Completed
Completed
Active, not recruiting
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications
Completed
Terminated
Completed
Completed
Recruiting
Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis
Site data: ClinicalTrials.govUpdated 18 Nov 2026